A. Morganti

BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis

Talmadge E. King, Kevin M. Brown, Ganesh Raghu et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 708 citations

Irinotecan Plus Gemcitabine Results in No Survival Advantage Compared With Gemcitabine Monotherapy in Patients With Locally Advanced or Metastatic Pancreatic Cancer Despite Increased Tumor Response Rate

Caio M. Rocha Lima, Mark R. Green, Robert Rotche et al. · Journal of Clinical Oncology · 2004 · 580 citations · Full text

Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension

Xavier Jaïs, Andrea Maria D’Armini, Pavel Jansa et al. · Journal of the American College of Cardiology · 2008 · 542 citations

Thrombosis, Hypertension, Heart Failure +7

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

Marco Matucci‐Cerinic, D.E. Furst, Maureen D. Mayes et al. · Annals of the Rheumatic Diseases · 2010 · 489 citations · Full text

Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial

Ganesh Raghu, Rachel Million-Rousseau, A. Morganti et al. · European Respiratory Journal · 2013 · 273 citations · Full text

Fibrosis, Antifibrotic Therapy, Inflammatory Lung Disease +12